Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Leases (2019 - 2025)

Marimed (MRMD) has disclosed Leases for 7 consecutive years, with $8.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Leases rose 86.37% to $8.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.0 million, a 86.37% increase, with the full-year FY2024 number at $4.1 million, up 23.61% from a year prior.
  • Leases was $8.0 million for Q3 2025 at Marimed, down from $8.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $9.7 million in Q3 2023 to a low of $46000.0 in Q4 2021.
  • A 5-year average of $4.5 million and a median of $4.3 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: tumbled 99.12% in 2021, then surged 10619.57% in 2022.
  • Marimed's Leases stood at $46000.0 in 2021, then soared by 10619.57% to $4.9 million in 2022, then crashed by 33.18% to $3.3 million in 2023, then grew by 23.61% to $4.1 million in 2024, then surged by 95.75% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Leases are $8.0 million (Q3 2025), $8.3 million (Q2 2025), and $4.0 million (Q1 2025).